Search

Search Results

• Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)

  Przemysław Żelazny, Joanna Filipczak, Oliwer Sygacz, Sebastian Bróż, Sara Dankiewicz, Aleksandra Swora, Joanna Borowik, Wojciech Brodowski, Piotr Pawłowski, Katarzyna Basta-Arciszewska

  583-588

  2022-09-08
• From VICTORIA to VICTOR: Where Vericiguat Fits in HFrEF Care

  Katarzyna Skibicka, Weronika Wesołowska, Albert Jaśniak, Robert Bujak

  65624

  2025-09-24
• SGLT2 inhibitors - a breakthrough in treatment of heart failure and their multipotential beneficial role in cardiology, diabetology, nephrology and neurology

  Marta Bogowska, Aleksandra Berner, Klaudia Marczyk, Karolina Matyja, Anna Olszewska, Maciej Pękała, Paulina Polak, Monika Polaszek, Karina Stelmaszak, Katarzyna Stencel

  185-199

  2023-10-03
• Vericiguat – possibly next weapon to overcome heart failure. Review of latest literature

  Mikolaj Biskupski, Aleksandra Cygnarowicz, Aneta Klaudia Wojtas, Krystyna Zabojska, Urszula Korotko, Aneta Mandziuk, Kinga Witowska, Mariola Turemka, Negar Hosseinnejad, Karolina Sacher

  56619

  2024-12-18
• Natriuretic peptide pathways in heart failure in the context of the analysis of the mechanism of action and potential usages of sacubitril/valsartan

  Kamila Babkiewicz-Jahn, Justyna Matuszewska, Adrianna Szymańska, Wiktoria Wilanowska, Izabela Oleksak, Karolina Maliszewska, Natalia Załęska

  50185

  2024-05-14
• Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy: Clinical Practice Update

  Katarzyna Skibicka, Weronika Wesołowska, Tomasz Skibicki, Robert Bujak

  65615

  2025-09-24
• SGLT2-Inhibitors - significant role in Heart Failure treatment

  Karol Wielgus, Piotr Bator, Maria Pawłowska, Karol Magiera, Krystian Rachwał, Maria Antos, Jan Ramian, Grzegorz Łyko

  49418

  2024-05-22